G62.0
Drug-induced polyneuropathy
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
Drug-induced polyneuropathy is a condition where nerve damage occurs as a result of adverse effects from certain medications. This condition affects multiple peripheral nerves, which can impair sensory, motor, or autonomic functions. Recognizing the symptoms and understanding the causes can help in early detection and management of this condition.
Causes & Symptoms
Clinical Causes: Use of certain medications such as chemotherapy agents, antibiotics, and anticonvulsants Prolonged exposure to neurotoxic drugs High doses of specific medications Combination of multiple drugs that may have neurotoxic effects Pre-existing nerve conditions that may be exacerbated by medication
Key Symptoms: Numbness or tingling sensation, especially in hands and feet Muscle weakness or weakness in limbs Difficulty with coordination or balance Burning sensation or pain in affected areas Sensitivity to touch Loss of reflexes Autonomic symptoms like abnormal blood pressure or digestive issues
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical history review, including medication use and duration. Physical and neurological examinations assess sensory and motor functions. Additional tests such as nerve conduction studies, electromyography (EMG), and blood tests can help rule out other causes and confirm nerve damage associated with medication use.
Treatment Protocols: Treatment primarily focuses on discontinuing or adjusting the offending medication. Symptomatic management may include pain relief strategies, physical therapy to maintain muscle strength and coordination, and monitoring for potential progression. In some cases, switching to alternative medications less likely to cause nerve damage is recommended.
Clinical Advice & FAQs
Billing Guidance
Is G62.0 a billable ICD-10 code?
Yes, G62.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G62.0?
Clinical documentation must specify the nature of Drug-induced polyneuropathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
